Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/26/2025

DVT Prophylaxis Post Hip Replacement: Type and Duration

  • The American Geriatrics Society recommends low molecular weight heparin (LMWH) as the preferred method of DVT prophylaxis for patients undergoing hip replacement surgery, with a recommended duration of at least 10-14 days and extended up to 35 days postoperatively 1, 2
  • The American College of Cardiology and other guidelines suggest that LMWH should be started either 12 hours before surgery, 12-24 hours after surgery, or 4-6 hours after surgery (starting with half-dose and continuing with usual high-risk dose the following day) 3, 2
  • Fondaparinux is considered an equal alternative to LMWH according to more recent guidelines from the Journal of Thrombosis and Haemostasis 4, 5
  • Adjusted-dose warfarin (target INR 2.5, range 2.0-3.0) is an acceptable alternative but more complex to manage and potentially less effective than LMWH, as stated by the American Geriatrics Society 1, 4
  • Direct oral anticoagulants (DOACs) like rivaroxaban (10 mg once daily) and apixaban have shown efficacy in VTE prevention after hip replacement, according to the Mayo Clinic Proceedings 5
  • Rivaroxaban has demonstrated reduced DVT, PE, or death without increased bleeding rates compared to enoxaparin in the RECORD trials, as reported by the Mayo Clinic Proceedings 5

Duration of Prophylaxis

  • The American Geriatrics Society recommends a minimum duration of 7-10 days for all patients undergoing hip replacement 1, 3
  • Extended prophylaxis beyond hospital discharge is strongly recommended as the risk of DVT persists for up to 2-3 months following hip replacement, according to the American Geriatrics Society 1
  • Extended prophylaxis (approximately 5 weeks total) has been shown to significantly reduce the continuing risk of DVT (12-37%) in six randomized double-blind trials, as stated by the American Geriatrics Society 1
  • The RECORD 2 trial demonstrated that extended rivaroxaban (31-39 days) was more effective than shorter-duration enoxaparin (10-14 days) without increased bleeding complications, according to the Mayo Clinic Proceedings 5

Mechanical Prophylaxis

  • Intermittent pneumatic compression (IPC) devices or elastic stockings may provide additional efficacy when used in conjunction with pharmacological prophylaxis (Grade 2C), as recommended by the American Geriatrics Society 1, 2
  • Mechanical prophylaxis alone is recommended only in patients with high bleeding risk, according to the Journal of Thrombosis and Haemostasis 4, 2
  • Combined use of mechanical and pharmacological methods may offer superior protection compared to either method alone, as stated by the American Geriatrics Society and the Journal of Thrombosis and Haemostasis 1, 2

Special Considerations

  • The risk of bleeding at the surgical site and wound hematoma may be greater with LMWH than with adjusted-dose warfarin, so the choice should be individualized based on bleeding risk, according to the American Geriatrics Society 1
  • Major bleeding occurred in 3.3% of warfarin recipients versus 5.3% of LMWH recipients in pooled data from five large clinical trials, as reported by the Journal of Thrombosis and Haemostasis 4
  • For patients at high risk of bleeding, mechanical prophylaxis should be used until the bleeding risk decreases, according to the Journal of Thrombosis and Haemostasis and the American College of Chest Physicians 4, 2

Implementation Challenges

  • Despite strong evidence and guidelines, compliance with recommended DVT prophylaxis after hip replacement varies geographically, according to the Journal of Thrombosis and Haemostasis 7, 8
  • In the US, approximately 84-93% of hip replacement patients receive some form of VTE prophylaxis, though not always according to guidelines, as reported by the Journal of Thrombosis and Haemostasis 8, 9
  • Clinical decision support tools and standardized order sets have been shown to improve compliance with VTE prophylaxis guidelines, according to the Journal of Thrombosis and Haemostasis 9